Speaker illustration

Professor Ana Cebrian

General University Hospital Santa Lucia, Cartagena (Spain)

he why and the how of cardiovascular risk management with SGLT2 inhibitors in the primary care setting: a tutorial for general practitioners

Event: ESC Congress 2025

Topic: Cardiovascular Disease in Primary Care

Session: The why and the how of cardiovascular risk management with SGLT2 inhibitors in the primary care setting: a tutorial for general practitioners

Thumbnail

The why and the how of cardiovascular risk management with SGLT2 inhibitors in the primary care setting: a tutorial for general practitioners

Event: ESC Congress 2025

Topic: Cardiovascular Disease in Primary Care

Session: The why and the how of cardiovascular risk management with SGLT2 inhibitors in the primary care setting: a tutorial for general practitioners

Thumbnail

ESC 365 is supported by